REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 182 filers reported holding REGENXBIO INC in Q2 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,755,172 | -16.5% | 106,634 | +1.4% | 0.00% | 0.0% |
| Q2 2023 | $2,101,388 | +107663.5% | 105,122 | +1.9% | 0.00% | 0.0% |
| Q1 2023 | $1,950 | -13.8% | 103,146 | +3.4% | 0.00% | -33.3% |
| Q4 2022 | $2,263 | -99.9% | 99,782 | -3.8% | 0.00% | -25.0% |
| Q3 2022 | $2,740,000 | +13.9% | 103,680 | +6.5% | 0.00% | 0.0% |
| Q2 2022 | $2,405,000 | -17.1% | 97,355 | +11.4% | 0.00% | 0.0% |
| Q1 2022 | $2,902,000 | +8.2% | 87,427 | +6.6% | 0.00% | +33.3% |
| Q4 2021 | $2,681,000 | -24.0% | 81,984 | -2.6% | 0.00% | -40.0% |
| Q3 2021 | $3,527,000 | -2.2% | 84,147 | -9.3% | 0.01% | 0.0% |
| Q2 2021 | $3,605,000 | +30.5% | 92,781 | +14.5% | 0.01% | +25.0% |
| Q1 2021 | $2,763,000 | -14.9% | 81,012 | +13.2% | 0.00% | 0.0% |
| Q4 2020 | $3,247,000 | +55.4% | 71,579 | -5.8% | 0.00% | +33.3% |
| Q3 2020 | $2,090,000 | -34.5% | 75,958 | -12.3% | 0.00% | -40.0% |
| Q2 2020 | $3,190,000 | +7.4% | 86,606 | -5.6% | 0.01% | -16.7% |
| Q1 2020 | $2,970,000 | -18.5% | 91,730 | +3.1% | 0.01% | 0.0% |
| Q4 2019 | $3,644,000 | +28.8% | 88,934 | +11.9% | 0.01% | +20.0% |
| Q3 2019 | $2,830,000 | -31.1% | 79,482 | -0.6% | 0.01% | -37.5% |
| Q2 2019 | $4,108,000 | -1.8% | 79,962 | +9.5% | 0.01% | 0.0% |
| Q1 2019 | $4,184,000 | +35.1% | 73,009 | -1.1% | 0.01% | +14.3% |
| Q4 2018 | $3,096,000 | -27.1% | 73,809 | +31.2% | 0.01% | -12.5% |
| Q3 2018 | $4,247,000 | +5.1% | 56,252 | -0.2% | 0.01% | 0.0% |
| Q2 2018 | $4,042,000 | +395.3% | 56,338 | +106.1% | 0.01% | +300.0% |
| Q1 2018 | $816,000 | -11.2% | 27,336 | -1.1% | 0.00% | 0.0% |
| Q4 2017 | $919,000 | +0.9% | 27,651 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $911,000 | +69.3% | 27,651 | +1.5% | 0.00% | +100.0% |
| Q2 2017 | $538,000 | +48.6% | 27,251 | +45.5% | 0.00% | 0.0% |
| Q1 2017 | $362,000 | +10.0% | 18,731 | +5.6% | 0.00% | 0.0% |
| Q4 2016 | $329,000 | +18.3% | 17,733 | -10.7% | 0.00% | 0.0% |
| Q3 2016 | $278,000 | +87.8% | 19,858 | +7.3% | 0.00% | – |
| Q2 2016 | $148,000 | – | 18,508 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |